Therefore, RENT3B has the potential to serve as a prognostic biomarker for hepatocellular carcinoma and lung squamous cell carcinoma, which may contribute to the development of immune-based anti-tumor strategies and the improvement of cancer patients’ prognosis. The gene discussed is UPF3B; the disease is cancer.